The inequality of vaccination coverage between urban and rural areas in sub-Saharan Africa: The caregiversâ?? perspective
7th Middle East - Global Summit and Expo on Vaccines & Vaccination
September 28-29, 2015 Dubai, UAE

Trésor Bodjick Muena Mujobu

University of Kinshasa, D R Congo

Scientific Tracks Abstracts: J Vaccines Vaccin

Abstract:

Inhomogeneous vaccination coverage between urban and rural areas is one of the hurdles to the achievement of a vaccinepreventable disease free world. Sub-Saharan Africa is most affected by the phenomenon. As far as the community is concerned, the main player in childhood vaccination is the mother, the one who cares for the child. The determinants that affect the awareness of the caregiver, the mother, about vaccination, the decision and motivation to bring the child to the health center to receive vaccines form the focus of this work. The main objective of the work was to identify bottlenecks to mothers�?? commitment to get their children vaccinated in rural areas and then to make proposals for improvement. DHS data were the main source of information about within countries urban/rural vaccination coverage. Four countries (Nigeria, Tanzania, South Africa and Democratic Republic of Congo) were picked for their geographic and demographic representativeness. PubMed was mainly used and secondarily African Index Medicus to find the maternal determinants of vaccination coverage. Main maternal factors of immunization were: Mother�??s education, household wealth index, media access, distance to the nearest clinic, service provision and vaccine supply, and others. For a mother or any other caregiver to take a child to the vaccination center, information about the benefits of immunization, ability to comprehend the information, motivation, accessibility of vaccination centers, availability of vaccines and healthcare providers at the center are needed.

Biography :

Trésor Bodjick Muena Mujobu obtained his MD degree from the University of Kinshasa (D R Congo) in 2009 and has completed Post-graduate studies (2nd level MSc in Vaccinology and Pharmaceutical Clinical Development) from the University of Siena (Italy) in 2014. The topic of his Master thesis is the one outlined in this abstract. He is currently a Research Associate at the Clinical Pharmacology Unit of the University of Kinshasa, Faculty of Medicine, which is also the National Pharmacovigilance Center.

Email: bodjickmuenam@gmail.com